Privi Speciality Valuation Multiples

Privi Speciality is valued at $1.4B as of November 2026, a 4.9x revenue multiple. In the last 12 months, Privi Speciality revenue was $304M and Privi Speciality EBITDA was $74M.

Privi Speciality Overview

About Privi Speciality

Privi Speciality Chemicals makes aroma chemicals and specialty chemicals sold to fragrance and flavour houses and personal care firms globally. Plants are in Maharashtra. Headquartered in Mumbai.


Founded

1985

HQ

India

Employees

1.2K

Website

privi.com

Sectors

Financials (LTM)

Revenue: $304M
EBITDA: $74M

EV

$1.5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Privi Speciality Financials

Privi Speciality reported last 12-month revenue of $304M and EBITDA of $74M.

In the same LTM period, Privi Speciality generated $74M in EBITDA and $38M in net income.

Revenue (LTM)


Privi Speciality P&L

In the most recent fiscal year, Privi Speciality reported revenue of $270M and EBITDA of $71M.

Privi Speciality is profitable as of last fiscal year, with gross margin of 46%, EBITDA margin of 26%, and net margin of 13%.

See analyst estimates for Privi Speciality
LTMLast FY202320242025202620272028
Revenue$304M$270M$181M$212M$257M
Gross Profit-$124M$56M$74M$98M
Gross Margin-46%31%35%38%
EBITDA$74M$71M$34M$47M$65M
EBITDA Margin24%26%19%22%25%
EBIT Margin21%20%10%15%19%
Net Profit$38M$35M$8M$17M$31M
Net Margin13%13%4%8%12%
Net Debt-$104M---

Financial data powered by Morningstar, Inc.

Privi Speciality Stock Performance

Privi Speciality has current market cap of $1.4B, and enterprise value of $1.5B.

Market Cap Evolution


Privi Speciality's stock price is $35.78.

Privi Speciality share price increased by 6.1% in the last 30 days, and by 1.1% in the last year.

Privi Speciality has an EPS (earnings per share) of $0.89.

See more trading valuation data for Privi Speciality
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.5B$1.4B0.0%6.1%-1.7%1.1%$0.89

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Privi Speciality Valuation Multiples

Privi Speciality trades at 4.9x EV/Revenue multiple, and 20.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Privi Speciality

EV / Revenue (LTM)


Privi Speciality Financial Valuation Multiples

As of November 9, 2026, Privi Speciality has market cap of $1.4B and EV of $1.5B.

Privi Speciality has a P/E ratio of 36.6x.

LTMLast FY202320242025202620272028
EV/Revenue4.9x5.5x8.2x7.0x5.8x
EV/EBITDA20.1x21.1x44.0x31.7x22.8x
EV/EBIT23.7x27.6x81.0x47.6x30.5x
EV/Gross Profit-12.0x26.5x20.1x15.1x
P/E36.6x40.1x172.4x80.7x45.2x
EV/FCFn/m93.1xn/mn/m162.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Privi Speciality Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Privi Speciality Margins & Growth Rates

Privi Speciality grew revenue by 21% and EBITDA by 11% in the last fiscal year.

In the most recent fiscal year, Privi Speciality reported gross margin of 46%, EBITDA margin of 26%, and net margin of 13%.

See estimated margins and future growth rates for Privi Speciality

Privi Speciality Margins

Last FY202420252026202720282029
Gross Margin46%35%38%34%
EBITDA Margin26%22%25%24%
EBIT Margin20%15%19%21%
Net Margin13%8%12%13%
FCF Margin6%(3%)4%(1%)

Privi Speciality Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth21%17%21%22%
Gross Profit Growth-32%33%6%
EBITDA Growth11%39%39%17%
EBIT Growth28%70%56%34%
Net Profit Growth17%114%78%27%
FCF Growth(165%)(219%)(272%)(142%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Privi Speciality Operational KPIs

Privi Speciality's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Privi Speciality's Rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Privi Speciality's Rule of X is 79% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Privi Speciality
LTMLast FY202320242025202620272028
Rule of 4049%46%---
Bessemer Rule of X85%79%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-5%4%5%5%
R&D Expenses to Revenue-0%0%0%0%
Opex to Revenue-26%21%20%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Privi Speciality Competitors

Privi Speciality competitors include Anupam Rasayan India, Saudi Chemical, CropEnergies, Supreme Petrochem, Sudeep Pharma, CAC Nantong Chemical Co, BASF India, Elementis, JSW Dulux and DCM Shriram.

Most Privi Speciality public comparables operate across Chemicals.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Anupam Rasayan India$247M$56M7.3x6.4x32.5x27.1x
Saudi Chemical$1.8B$147M0.9x-11.4x-
CropEnergies$5M($40M)270.8x1.0x(35.0x)11.8x
Supreme Petrochem$573M$57M2.3x1.8x22.9x16.5x
Sudeep Pharma$68M$26M21.0x18.9x54.7x53.6x
CAC Nantong Chemical Co$806M$155M2.0x1.7x10.2x-
BASF India$1.6B$73M0.8x0.8x17.9x13.5x
Elementis$598M$138M2.7x2.6x11.7x9.9x

This data is available for Pro users. Sign up to see all Privi Speciality competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Privi Speciality

When was Privi Speciality founded?Privi Speciality was founded in 1985.
Where is Privi Speciality headquartered?Privi Speciality is headquartered in India.
How many employees does Privi Speciality have?As of today, Privi Speciality has over 1K employees.
Is Privi Speciality publicly listed?Yes, Privi Speciality is a public company listed on Bombay Stock Exchange.
What is the stock symbol of Privi Speciality?Privi Speciality trades under 530117 ticker.
When did Privi Speciality go public?Privi Speciality went public in 2000.
Who are competitors of Privi Speciality?Privi Speciality main competitors include Anupam Rasayan India, Saudi Chemical, CropEnergies, Supreme Petrochem, Sudeep Pharma, CAC Nantong Chemical Co, BASF India, Elementis, JSW Dulux, DCM Shriram.
What is the current market cap of Privi Speciality?Privi Speciality's current market cap is $1.4B.
What is the current revenue of Privi Speciality?Privi Speciality's last 12 months revenue is $304M.
What is the current revenue growth of Privi Speciality?Privi Speciality revenue growth (NTM/LTM) is 24%.
What is the current EV/Revenue multiple of Privi Speciality?Current revenue multiple of Privi Speciality is 4.9x.
What is the current EBITDA of Privi Speciality?Privi Speciality's last 12 months EBITDA is $74M.
What is Privi Speciality's EBITDA margin?Privi Speciality's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Privi Speciality?Current EBITDA multiple of Privi Speciality is 20.1x.
What is the current FCF of Privi Speciality?Privi Speciality's last 12 months FCF is $1M.
What is Privi Speciality's FCF margin?Privi Speciality's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of Privi Speciality?Current FCF multiple of Privi Speciality is 1020.1x.
How many companies Privi Speciality has acquired to date?Privi Speciality hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Privi Speciality has invested to date?Privi Speciality hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Privi Speciality

Lists including Privi Speciality

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial